Dutasteride Capsule, Liquid Filled
Product Images NDC 68071-4821

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 11 technical images submitted to the FDA as part of the official labeling for Dutasteride (NDC 68071-4821). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Nucare Pharmaceuticals,inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Pdp (68071 4821 9)

Pdp (68071 4821 9)
This seems to be a pharmaceutical label. The product is Dutasteride, which comes in 0.5mg capsules with 90 capsules per container. The label contains important information that a patient should read before taking the medication, such as the warning to keep it out of reach of children and to store it at a controlled temperature. There are also details about the manufacturer, the lot number, and the expiration date. Finally, there is a reminder to call a doctor before taking the medication if the patient is unsure of its safety.*
FDA Label Image

Fig1 (Fig1)

FDA Label Image

Fig2 (Fig2)

FDA Label Image

Fig3 (Fig3)

FDA Label Image

Fig4 (Fig4)

FDA Label Image

Fig5 (Fig5)

FDA Label Image

Fig6 (Fig6)

FDA Label Image

Fig7 (Fig7)

FDA Label Image

Structure (Structure)

FDA Label Image

Tab1 (Tab1)

Tab1 (Tab1)
This is a chart showing the adverse reactions and their time of onset for Dutasteride and Placebo drugs over a period of 24 months. The adverse reactions measured were impotence, decreased libido, ejaculation disorders, and breast disorders. The chart indicates the percentage of occurrence of these reactions for each drug at different time intervals.*
FDA Label Image

Tab2 (Tab2)

Tab2 (Tab2)
The given text seems to be a table representing the adverse reactions caused by different drugs - Combination, Dutasteride, and Tamsulosin. The reactions are documented with respect to year and months of usage and the percentage of patients affected with the reaction. The adverse reactions include Ejaculation disorders, impotence, decreased libido, Breast disorders, and Dizziness.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.